Publications

Sort by: Date | Author | Title

Petersen, E., Lucey, D., Blumberg, L., Kramer, L. D., Al-Abri, S., Lee, S. S., Pinto, T. D. C. A., Obiero, C. W., Rodriguez-Morales, A. J., Yapi, R., Abubakar, A., Tambyah, P. A., Holmes, A. & Chen, L. H. (2021). Answer to Paredes et al. commenting on “COVID-19 vaccines under the International Health Regulations — We must use the WHO International Certificate of Vaccination or Prophylaxis”. International Journal of Infectious Diseases, 105, 409-410. https://doi.org/10.1016/j.ijid.2021.02.076
Bohlbro, A. S., Mendes, A. M., Sifna, A., Patsche, C. B., Gomes, V., Wejse, C. & Rudolf, F. (2021). Assessing gender differences among presumed and diagnosed patients with pulmonary TB: observations from Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene, 115(11), 1273–1281. https://doi.org/10.1093/trstmh/trab145
Heilmann, E., Gregoriano, C., Wirz, Y., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., Christ-Crain, M., Bouadma, L., Annane, D., Damas, P., Kristoffersen, K. B., Oliveira, C. F., Stolz, D., Tamm, M., De Jong, E., Reinhart, K., Shehabi, Y., Verduri, A. ... Schuetz, P. (2021). Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: A patient-level meta-analysis from randomized controlled trials. Clinical Chemistry and Laboratory Medicine, 59(2), 441-453. https://doi.org/10.1515/cclm-2020-0931
Bastard, P., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Manry, J., Michailidis, E., Hoffmann, H. H., Eto, S., Garcia-Prat, M., Bizien, L., Parra-Martínez, A., Yang, R., Haljasmägi, L., Migaud, M., Särekannu, K., Maslovskaja, J., Prost, N. D., Tandjaoui-Lambiotte, Y. ... Imagine COVID Group (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6(62), Article 4340. https://doi.org/10.1126/sciimmunol.abl4340
Hoffmann, M., Hofmann-Winkler, H., Smith, J. C., Krüger, N., Arora, P., Sørensen, L. K., Søgaard, O. S., Hasselstrøm, J. B., Winkler, M., Hempel, T., Raich, L., Olsson, S., Danov, O., Jonigk, D., Yamazoe, T., Yamatsuta, K., Mizuno, H., Ludwig, S., Noé, F. ... Pöhlmann, S. (2021). Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine, 65, Article 103255. https://doi.org/10.1016/j.ebiom.2021.103255